These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 9452896

  • 1. Pap smear screening after hysterectomy.
    McIntosh DG.
    Compr Ther; 1998 Jan; 24(1):14-8. PubMed ID: 9452896
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Is cytologic screening an effective surveillance method for detection of vaginal recurrence of uterine cancer?
    Cooper AL, Dornfeld-Finke JM, Banks HW, Davey DD, Modesitt SC.
    Obstet Gynecol; 2006 Jan; 107(1):71-6. PubMed ID: 16394042
    [Abstract] [Full Text] [Related]

  • 4. Comparison of visual inspection of cervix and Pap smear for cervical cancer screening.
    Tayyeb R, Khawaja NP, Malik N.
    J Coll Physicians Surg Pak; 2003 Apr; 13(4):201-3. PubMed ID: 12718787
    [Abstract] [Full Text] [Related]

  • 5. [A project to improve the screening rate of pap smear for cervical cancer].
    Lin HH, Chen SH, Jeng SY, Chen HM.
    Hu Li Za Zhi; 2007 Feb; 54(1):62-9. PubMed ID: 17340549
    [Abstract] [Full Text] [Related]

  • 6. Vaginal cancer after hysterectomy for benign disease: value of cytologic screening.
    Bell J, Sevin BU, Averette H, Nadji M.
    Obstet Gynecol; 1984 Nov; 64(5):699-702. PubMed ID: 6493662
    [Abstract] [Full Text] [Related]

  • 7. Screening of cervical neoplasia by using pap smear with speculoscopy compared with pap smear alone.
    Boonlikit S, Supakarapongkul W, Preuksaritanond N, Vipupinyo C, Tuipae S, Mangclaviras S, Karnplumjid S, Chantarawiroj P.
    J Med Assoc Thai; 2005 Feb; 88(2):138-44. PubMed ID: 15962661
    [Abstract] [Full Text] [Related]

  • 8. Vaginal intraepithelial neoplasia III detected after hysterectomy for benign conditions.
    Ferris DG, Messing MJ, Crosby JH.
    J Fam Pract; 1995 Jan; 40(1):81-5. PubMed ID: 7807042
    [Abstract] [Full Text] [Related]

  • 9. Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study.
    Wong LP, Wong YL, Low WY, Khoo EM, Shuib R.
    Singapore Med J; 2009 Jan; 50(1):49-53. PubMed ID: 19224084
    [Abstract] [Full Text] [Related]

  • 10. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P, Vuorma S, Viikki M, Hakama M, Anttila A.
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M, Hoque E, Kader SB.
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [Abstract] [Full Text] [Related]

  • 12. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
    Rooker D, Baalbergen A, Helmerhorst TJ.
    Ned Tijdschr Geneeskd; 2008 Apr 26; 152(17):977-80. PubMed ID: 18549169
    [Abstract] [Full Text] [Related]

  • 13. Improved cervical cancer screening in premenopausal women by combination of Pap smear and speculoscopy.
    Twu NF, Chen YJ, Wang PH, Yu BK, Lai CR, Chao KC, Yuan CC, Yen MS.
    Eur J Obstet Gynecol Reprod Biol; 2007 Jul 26; 133(1):114-8. PubMed ID: 16797826
    [Abstract] [Full Text] [Related]

  • 14. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M, Daltveit AK, Thoresen SO, Nygård JF.
    BMC Health Serv Res; 2007 Jan 23; 7():10. PubMed ID: 17244348
    [Abstract] [Full Text] [Related]

  • 15. Sentinel Pap smears in 261 invasive cervical cancer patients in Italy.
    Igidbashian S, Maggioni A, Casadio C, Boveri S, Cristoforoni P, Sideri M.
    Vaccine; 2009 May 29; 27 Suppl 1():A34-8. PubMed ID: 19480959
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of visual inspection of the cervix using acetic acid in cervical cancer screening: a comparison with cervical cytology.
    Akinola OI, Fabamwo AO, Oshodi YA, Banjo AA, Odusanya O, Gbadegesin A, Tayo A.
    J Obstet Gynaecol; 2007 Oct 29; 27(7):703-5. PubMed ID: 17999297
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
    Sarian LO, Derchain SF, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, Gontijo R, Bragança JF, Lima TP, Maeda MY, Lörincz A, Dores GB, Costa S, Syrjänen S, Syrjänen K.
    J Med Screen; 2005 Oct 29; 12(3):142-9. PubMed ID: 16156945
    [Abstract] [Full Text] [Related]

  • 18. Pap smear utilization in Canada: estimates after adjusting the eligible population for hysterectomy status.
    Snider JA, Beauvais JE.
    Chronic Dis Can; 1998 Oct 29; 19(1):19-24. PubMed ID: 9550731
    [Abstract] [Full Text] [Related]

  • 19. Educational level and cervical cancer screening programs in a Venezuelan urban area.
    Núñez-Troconis J, Velásquez J, Mindiola R, Munroe D.
    Invest Clin; 2008 Sep 29; 49(3):331-9. PubMed ID: 18846774
    [Abstract] [Full Text] [Related]

  • 20. Knowledge, attitude, and practice of female health professionals regarding cervical cancer and Pap smear.
    Anya SE, Oshi DC, Nwosu SO, Anya AE.
    Niger J Med; 2005 Sep 29; 14(3):283-6. PubMed ID: 16350698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.